Penumbra, Inc.

NYSE:PEN Stock Report

Market Cap: US$10.0b

Penumbra Past Earnings Performance

Past criteria checks 5/6

Penumbra has been growing earnings at an average annual rate of 53.3%, while the Medical Equipment industry saw earnings growing at 14.1% annually. Revenues have been growing at an average rate of 17.5% per year. Penumbra's return on equity is 11.4%, and it has net margins of 11.5%.

Key information

53.28%

Earnings growth rate

52.51%

EPS growth rate

Medical Equipment Industry Growth8.90%
Revenue growth rate17.49%
Return on equity11.41%
Net Margin11.54%
Last Earnings Update30 Jun 2025

Recent past performance updates

We Think You Can Look Beyond Penumbra's (NYSE:PEN) Lackluster Earnings

Apr 30
We Think You Can Look Beyond Penumbra's (NYSE:PEN) Lackluster Earnings

Recent updates

Results: Penumbra, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Aug 01
Results: Penumbra, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Penumbra: AI Meets Aspiration - Why The Stock Is A Structural Winner

Jun 26

The Return Trends At Penumbra (NYSE:PEN) Look Promising

Jun 23
The Return Trends At Penumbra (NYSE:PEN) Look Promising

Why Investors Shouldn't Be Surprised By Penumbra, Inc.'s (NYSE:PEN) P/S

May 26
Why Investors Shouldn't Be Surprised By Penumbra, Inc.'s (NYSE:PEN) P/S

We Think You Can Look Beyond Penumbra's (NYSE:PEN) Lackluster Earnings

Apr 30
We Think You Can Look Beyond Penumbra's (NYSE:PEN) Lackluster Earnings

Earnings Beat: Penumbra, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Apr 26
Earnings Beat: Penumbra, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Penumbra Off And Running On Renewed Enthusiasm For Mechanical Thrombectomy

Mar 13

Penumbra (NYSE:PEN) Will Be Hoping To Turn Its Returns On Capital Around

Jan 27
Penumbra (NYSE:PEN) Will Be Hoping To Turn Its Returns On Capital Around

Penumbra: Re-Rated For The Wrong Reasons

Jan 07

Investors Appear Satisfied With Penumbra, Inc.'s (NYSE:PEN) Prospects

Dec 31
Investors Appear Satisfied With Penumbra, Inc.'s (NYSE:PEN) Prospects
User avatar

CAVT Technology Powers Thrombectomy Leader To Transformative Growth And Global Expansion

Introduction of CAVT technology positions Penumbra as a thrombectomy leader, driving revenue growth through innovation and market share gains.

Penumbra Grinding Through A Painful Growth Expectations Reset

Aug 20

Penumbra: Appeal Improves As Operating Leverage Continues

May 30

Penumbra: Appeal Improves, Just Not Appealing Yet

Oct 16

Penumbra: Consolidation Does Nothing To Change Long-Term Thesis, Reiterate Buy

Sep 01

Penumbra: Future Upside Drivers In Fundamental, Sentimental And Valuation Factors

Jun 22

Revenue & Expenses Breakdown

How Penumbra makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

NYSE:PEN Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 251,28014860191
31 Mar 251,2404258892
31 Dec 241,1951457495
30 Sep 241,1643555697
30 Jun 241,1341454292
31 Mar 241,0969352389
31 Dec 231,0599150684
30 Sep 239954149280
30 Jun 239382947581
31 Mar 23885646279
31 Dec 22847-245079
30 Sep 22830-3143981
30 Jun 22806-1942576
31 Mar 22782-640174
31 Dec 217485378105
30 Sep 217103437681
30 Jun 216711635890
31 Mar 21592-532793
31 Dec 20560-1628788
30 Sep 20539-1028572
30 Jun 205271127860
31 Mar 205563928653
31 Dec 195474827352
30 Sep 195234525950
30 Jun 194951524545
31 Mar 194711223240
31 Dec 18445722636
30 Sep 18420921634
30 Jun 183922820733
31 Mar 183631319633
31 Dec 17334518432
30 Sep 17311-717429
30 Jun 17294516628
31 Mar 17279915826
31 Dec 162631514824
30 Sep 162451813623
30 Jun 16228612521
31 Mar 16205311520
31 Dec 15186110218
30 Sep 1516709217
30 Jun 15149-18216
31 Mar 15138-17215
31 Dec 14126-16416

Quality Earnings: PEN has high quality earnings.

Growing Profit Margin: PEN's current net profit margins (11.5%) are higher than last year (1.3%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: PEN's earnings have grown significantly by 53.3% per year over the past 5 years.

Accelerating Growth: PEN's earnings growth over the past year (937.7%) exceeds its 5-year average (53.3% per year).

Earnings vs Industry: PEN earnings growth over the past year (937.7%) exceeded the Medical Equipment industry 12.6%.

Return on Equity

High ROE: PEN's Return on Equity (11.4%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/07 13:27
End of Day Share Price 2025/10/07 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Penumbra, Inc. is covered by 29 analysts. 21 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullBaird
David RescottBaird
Ishan MajumdarBaptista Research